74
Participants
Start Date
August 31, 2015
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
VTP-43742
VTP-43742 administered as an oral capsule once daily
Placebo 1
Placebo 1 matching VTP-43742 administered as an oral capsule once daily
Placebo 2
Placebo 2 matching VTP-43742 administered as an oral capsule once daily
Patient Site 2, New York
Patient Site 9, High Point
Patient Site 1, Miami
Patient Site 8, Tampa
Patient 12, Tampa
Patient Site 13, Carmel
Patient Site 4, Plainfield
Patient Site 5, Rogers
Patient Site 3, Dallas
Patient Site 10, Houston
Patient Site 11, Houston
Patient Site 7, Webster
Patient Site 6, College Station
Healthy Volunteer Site 1, Fair Lawn
Vitae Pharmaceuticals Inc., an Allergan affiliate
INDUSTRY